Physician profile
Duane E Bridges
NPI 1154352011
$51,362.59
in general payments reported to CMS, 2019-2025
28 companies · $13K in 2025
The $13K reported for 2025 was more than what 84% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $6,307 · 2021: $1,365 · 2022: $6,433 · 2023: $2,794 · 2024: $4,212 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $11K · Food and Beverage: $9,522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $10,729.55 |
| Food and Beverage | $9,522.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $28,123.95 | 2019-2025 | Acticor 7 Vr-T Dx, Rivacor 7 Dr-T, Selectra |
| Medtronic, INC. | $10,268.49 | 2021-2025 | Micra, Evera Mri Xt Dr Surescan, Affera Mapping System |
| Boston Scientific Corporation | $6,043.58 | 2019-2025 | Farapulse, General - Therapies, Lux-Dx Insertable Cardiac Monitor |
| Abbott Laboratories | $1,924.83 | 2020-2025 | Amplatzer Amulet, Aveir, Amplatzer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $768.78 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $757.55 | 2019-2025 | Camzyos, Eliquis |
| Kestra Medical Technology Services, INC. | $705.09 | 2022-2024 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $653.10 | 2019-2024 | |
| Impulse Dynamics (USA) INC. | $355.36 | 2023-2025 | Optimizer, Optimizer |
| Medtronic Vascular, INC. | $329.75 | 2020 | |
| Acutus Medical, INC. | $293.37 | 2019-2021 | |
| Pfizer INC. | $182.06 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $162.37 | 2021-2024 | Verquvo |
| Arbor Pharmaceuticals, INC. | $123.42 | 2019-2021 | |
| Cvrx, INC. | $115.66 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $115.63 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $92.73 | 2020-2021 | |
| Atricure, INC. | $47.88 | 2019-2020 | |
| Biosense Webster, INC. | $43.42 | 2023-2025 | Carto 3 |
| Novartis Pharmaceuticals Corporation | $43.19 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.97 | 2024 | Jardiance |
| Teleflex LLC | $37.38 | 2019-2020 | |
| Cardiva Medical, INC. | $36.87 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Biom'Up France Sas | $23.86 | 2020 | |
| Bardy Diagnostics, INC. | $20.00 | 2022 | |
| Janssen Pharmaceuticals, INC | $19.84 | 2021 | |
| Abiomed | $19.48 | 2019 | |
| Alnylam Pharmaceuticals INC. | $13.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Duane Bridges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.